Navigation Links
InaVein, LLC Announces First Peer-reviewed Publication of TRIVEX® Used In-Office
Date:10/20/2011

LEXINGTON, Mass., Oct. 20, 2011 /PRNewswire/ -- InaVein, LLC today announced publication of a peer-reviewed paper that examines use of the TRIVEX transilluminated powered phlebectomy (TIPP) System for removal of varicose veins in a clinical office rather than a hospital setting. The paper, Transilluminated Powered Phlebectomy in an Office Setting:  Procedural Considerations and Clinical Outcomes was authored by Gregory A. Spitz, M.D., FACS (AmeriVein Systems, Aurora, Illinois) and published in the October 2011 edition of the Journal of Endovascular Therapy.  The TRIVEX procedure was successfully completed on all patients using only local tumescent anesthesia.  There were no reports of hematomas, deep vein thrombosis, or extended parasthesia at the 3-month follow up.  Patients reported a high level of satisfaction (9.6 out of 10) in this setting. A mean procedure time of 13.5 minutes (+/-3.7 min) was reported.  Thirty-three of the 36 patients underwent concurrent endovenous ablation procedures.  According to Dr. Spitz, "More recent cases have confirmed that when patients are prepared for an in-office procedure and treated by a physician well versed in the TIPP procedure and tumescent anesthesia, the outcomes are mutually satisfying. There should also be an economic benefit, with reduced cost to the healthcare system, as has been realized in other clinical situations."  InaVein CEO Keith Jansen said, "This clinical evidence highlights the benefits of the TRIVEX procedure in an office environment for patients who have varicose veins -- a condition that impacts 25 - 40 million Americans and over 700 million people globally."

About InaVein

InaVein, LLC is a privately held company engaged in the development, manufacture, marketing and commercialization of unique medical devices for the treatment of vein disease. The company's flagship product, The TRIVEX System, is the first technology to provide vein specialists with a minimally invasive technique to remove varicose veins safely and efficiently under direct vision. Since 2003, thousands of patients worldwide have been successfully treated using The TRIVEX System in a surgical setting to completely remove their varicose veins.

For more information please contact:
InaVein, LLC
Keith Jansen
President & CEO
617.245.1965 ext. 1102
Email: kjansen@inavein.com

Website: www.inavein.com


'/>"/>
SOURCE InaVein, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Epilepsy Therapy Project Announces "Shark Tank" Competition to Identify the Most Innovative, New Products for People with Epilepsy
2. China Nuvo Solar, Inc. Announces Corporate Name Change to SurgLine International, Inc.
3. Misonix Announces the Sale of Its Laboratory and Forensic Safety Products Business for $1.5 Million
4. The Society for Minimally Invasive Spine Surgery Announces Agreement With joimax® to Support Creation and Launch of SMISS Registry for Endoscopic Spine Surgery
5. WaferGen Announces Organizational Changes to Enhance Commercialization of SmartChip System
6. Sequenom, Inc. Announces Date of Third Quarter 2011 Financial Results and Conference Call
7. Bend Research Announces New Chief Financial Officer
8. Young Innovations, Inc. Announces Record EPS for the Quarter and Record Sales and EPS for the Nine-Months Ended September 30, 2011 and Declares Quarterly Dividend
9. Amgen Announces Webcast of 2011 Third Quarter Financial Results
10. Pacira Pharmaceuticals, Inc. Announces New Data Demonstrating Longer Time to First Opioid Use and Reduction in Opioid-Related Adverse Events With EXPAREL™ Compared to Bupivacaine HCl
11. Robertson Global Health Solutions Announces Commercial Venture with Telemedicine Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation ... and home sensors for real-time monitoring of patients with ... nonprofit organization focused on disruptive health solutions for rare ... system to record and integrate behavioral, cognitive, physiological and ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
(Date:10/12/2017)... Mich. (PRWEB) , ... October 12, 2017 , ... ... has been named one of Michigan’s 2017 Best and Brightest in Wellness® by ... Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the ... a year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, ... retirement havens have extremely low property-tax rates, which contributes to the relatively lower ...
(Date:10/12/2017)... ... 12, 2017 , ... Farm Forward joins Bon ... leading institutions in announcing the launch of the Leadership Circle , a ... are raised for food. , Founding members of the Leadership Circle also include ...
Breaking Medicine News(10 mins):